EP0881229B1 — Alkylated antibiotic hexapeptides
Assigned to Eli Lilly and Co · Expires 2003-07-09 · 23y expired
What this patent protects
The present invention is directed to N<1>-alkylated derivatives of desleucyl A82846B. These derivatives are useful as antibacterials and also as starting materials from which further antibacterial compounds are prepared. <CHEM>
USPTO Abstract
The present invention is directed to N<1>-alkylated derivatives of desleucyl A82846B. These derivatives are useful as antibacterials and also as starting materials from which further antibacterial compounds are prepared. <CHEM>
Drugs covered by this patent
- Vibativ (TELAVANCIN HYDROCHLORIDE) · Cumberland
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.